CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER j: MATERNAL AND CHILD HEALTH
PART 663 SICKLE CELL DISEASE PREVENTION, CARE, AND TREATMENT PROGRAM
SUBPART A: GENERAL PROVISIONS
Section 663.10 Definitions
Section 663.20 Incorporated and Referenced Materials
SUBPART B: SICKLE CELL PREVENTION, CARE, AND TREATMENT ACT GRANTS
Section 663.100 Eligibility for Grant Program Award for Sickle Cell Prevention, Care, and Treatment and for Sickle Cell Education and Outreach
Section 663.110 Grant Requirements
Section 663.120 Allowable Uses of Grant Funds and Reimbursement Procedures and Requirements
Section 663.130 Suspension or Termination of Grant Award
SUBPART C: SICKLE CELL STATEWIDE IMPACT AND SURVEILLANCE PROGRAM
Section 663.200 Sickle Cell Statewide Impact and Surveillance Program
SUBPART A: GENERAL PROVISIONS
![]() | ||||||||||||
Title 77: Public Health
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH SUBCHAPTER j: MATERNAL AND CHILD HEALTH PART 663 SICKLE CELL DISEASE PREVENTION, CARE, AND TREATMENT PROGRAM SECTION 663.10 DEFINITIONS
Section 663.10 Definitions
For the purpose of this Part, the following shall be the accepted definitions of the terms used in this Part:
"Act" means the Sickle Cell Prevention, Care, and Treatment Program Act [410 ILCS 460].
"Department" or "DPH" means the Illinois Department of Public Health or its designee.
"Director" means Director of the Illinois Department of Public Health.
"Hemoglobinopathies" means rare inborn disorders that impair the red blood cells' ability to carry oxygen to the body's organs and tissues.
"Fund" means the Sickle Cell Chronic Disease Fund as established by the Act.
"Funding period" means the time (usually 12 months coinciding with the Department's fiscal year) during which money is to be spent by award recipients.
"Program" means the Sickle Cell Prevention, Care, and Treatment Program. (Section 131-5 of the Act)
"Sickle cell disease" (SCD) and "sickling disorder" means a rare inborn disorder that impairs the red blood cells' ability to carry oxygen to the body's organs and tissues. A change in the shape of the red blood cells may occur, at times resembling a sickle shape.
"Sickle cell trait" (SCT) and "sickle trait" means the heritable change in the hemoglobin gene that is associated with sickle cell disease.
|

